Pages that link to "Q43037202"

The following pages link to Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia (Q43037202):

Displaying 42 items.

• Cancer cachexia--pathophysiology and management (Q24605567) (← links)
• Pathophysiology of anorexia in the cancer cachexia syndrome (Q26775294) (← links)
• Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and Vomiting (Q26784070) (← links)
• Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application (Q26830898) (← links)
• Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice (Q30410972) (← links)
• Ghrelin and cachexia: Will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes? (Q30426403) (← links)
• The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism. (Q30455563) (← links)
• Evaluating the various phases of cisplatin-induced emesis in rats (Q34293135) (← links)
• The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Q34647257) (← links)
• Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract (Q35030764) (← links)
• Herbal medicines for the treatment of cancer chemotherapy-induced side effects (Q35066654) (← links)
• A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction (Q35612563) (← links)
• Is Ghrelin Synthesized in the Central Nervous System? (Q36308369) (← links)
• Effect of immobilization stress on the appetite and stomach ghrelin expression in maternal mice (Q36511791) (← links)
• Changes in plasma ghrelin and serum leptin levels after Cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma (Q36711597) (← links)
• Serotonin and the regulation of mammalian energy balance (Q36718579) (← links)
• Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review (Q37691031) (← links)
• Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy (Q37726472) (← links)
• The potential of ghrelin in the treatment of cancer cachexia. (Q38053171) (← links)
• Clinical application of ghrelin in the field of surgery (Q38264663) (← links)
• Ghrelin enhancer, rikkunshito, improves postprandial gastric motor dysfunction in an experimental stress model (Q38278626) (← links)
• Anorexia in human and experimental animal models: physiological aspects related to neuropeptides (Q38540231) (← links)
• The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting (Q38677762) (← links)
• Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02). (Q38705385) (← links)
• Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting (Q38739169) (← links)
• Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients (Q39266110) (← links)
• Antiemetic research: future directions. (Q39818791) (← links)
• Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study (Q41605478) (← links)
• Rikkunshito, a Japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model. (Q41965543) (← links)
• Ghrelin and obestatin modulate growth hormone-releasing hormone release and synaptic inputs onto growth hormone-releasing hormone neurons. (Q44478611) (← links)
• Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight. (Q47245585) (← links)
• The role of central 5-HT(2C) and NMDA receptors on LPS-induced feeding behavior in chickens (Q48459728) (← links)
• Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study (Q48491599) (← links)
• Decreased plasma ghrelin contributes to anorexia following novelty stress (Q49117002) (← links)
• Effects of ghrelin on nocturnal melatonin secretion in sheep: An in vitro and in vivo approach (Q49386200) (← links)
• Protective Effect of D-Methionine on Body Weight Loss, Anorexia, and Nephrotoxicity in Cisplatin-Induced Chronic Toxicity in Rats. (Q50070153) (← links)
• An Herbal Medicine, Yukgunja-Tang is more Effective in a Type of Functional Dyspepsia Categorized by Facial Shape Diagnosis: A Placebo-Controlled, Double-Blind, Randomized Trial (Q58592420) (← links)
• Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences (Q59800503) (← links)
• Arcuate Nucleus Orexin-A Signaling Alleviates Cisplatin-Induced Nausea and Vomiting Through the Paraventricular Nucleus of the Hypothalamus in Rats (Q60951312) (← links)
• Therapeutic strategies against cancer cachexia (Q64094688) (← links)
• Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan (Q82492037) (← links)
• Pituitary immunoexpression of ghrelin in anorexia nervosa (Q82493267) (← links)